Member Info for Lazarus2

That would be a very long response Rich3R - I respectfully suggest you read the RNS releases. Plenty has been happening which the news releases will explain in full.

Definitely benefitting from Sector sentiment and the rise in general. I also suspect that profit takers in the other shares are buying in here as their next big opportunity. Really puts Sareum back on the radar. Very good buying volume here.

If it helps Bailiff, I share Guitarsolo's approach and I buy despite any trepidation. The end game will hopefully dwarf the odd penny here and there. Good luck whatever you decide.

Best of luck to you Guitarsolo. Sareum is on the cusp of a re-rate

Yep - looks as if they are selling at 23p so some momentum here

All decent points guys and I would observe that the trial results and the AI collaboration outcomes dovetail neatly into end of year(ish) which would be 12 months since the original Ph1 results and the right sort of timeline for negotiations to take place. Might be coincidence of dates but I am sure that positive news of some description will be forthcoming

…to news but, in particular, the end of the trial with nothing adverse reported. It would be great to see the BoD pump up the PR activity if they are able to. AI collaboration is early days yet so all eyes on the immediate news including the results RNS which will contain the Chairman’s forward looking statement. He will definitely want something positive to report.

Great opportunity here assuming we are successful.

Follow the news and DYOR but it is all very close. Make or break I would say in the next few months

I agree Elcap. Buying has slowed but still some chunky buys going through. MM's must have access to a fistful of shares as there is little evidence of selling as of yet. They cannot be relying on us ordinary folk to sell down at these levels so will have to raise the sp in order to attract sellers.

Looking at the first hours volume and the size of the trades I would say that it may well have started.. SP unchanged though

I agree that the BoD would prefer a buyout but it is purely down to any interested party as to whether they buy or license. They do have their shareholders to consider so won’t be rash. Sareum stated strategy is as Potnak has pointed out. However, I also believe that if upcoming trial results are positive it may attract more than one suitor for Sareum. I am not into predicting the shareprice but if the stars align at the end of the trials then I would expect an offer to be made based upon the fact that we have, potentially, a ready made and exciting pipeline. As ever, time is the test of all things.

Good post SoG - I am in total agreement. If their current trial and collaboration indicate a high probability of success then the opportunities appear to be boundless. September tomorrow and much to look forward to. If big Pharma is interested, it would be in their interest and their shareholders interest to move quickly and to take the opportunity as cheaply as possible. Lots of new data will dovetail into end November/December although I think data information and progress will be monitored by Sareum. All to play for

Hope so - those late reported trades may be to balance the books but the 100k is a buy going on today’s price action. We have also had two uncrossing trades in one day - bit unusual. The sp is definitely being skewed but the mm’s not taking it down. September next week and ever closer to end of Tox study. All to play for.

The last 4 trades showing as sells are, in fact, buys.

Our 10k buyer is back which may bode well going forwards

Good point Potnak which is why I queried 1802 application in Brain cancers.

@HBD - I get your point but I would be pretty cheesed off if there was no financial reward for this collaboration. They are a commercial company. If cheap and/or willing to do the work then 1802 must be ripe for such a collaboration

I think the same Hopkirk. The warrants are a drag but if it means that they pay for the AI collaboration then I am fine with that. Basically if the warrant holder exercises and gets their original stake back they will be tempted to retain the remainder on a free carry. After all, they did back the Company during difficult times so best of luck to them I say. Should the sp climb again on any positive news I am sure other warrants will be exercised and will act as a similar brake. I wouldn't sweat the small stuff. The science will, hopefully, provide significant value going forwards and warrant conversions will be in the rear view mirror.

Yep! A total of £351k in recent weeks. Also being absorbed quite well. Seems as if there is demand for Sareum shares out there. It is September next week with no adverse reportable news with regards to the Tox study. We are fast approaching a major milestone event in Sareum's history and its future

Good read Megs - of course investors could always invest in Sareums pipeline and future by buying low at these levels. Much more simplistic but also realistic too

Good posts SoG - not just reassuring but rather exciting too. Confidence growing by the day. As an aside, if the AI model is positive does it follow that 1802 could be effective in treating Glioblastoma and metastatic brain cancer?

Really good research HBD and I, like others, are grateful to you. The credibility acts as a comfort blanket for us all going into Tuesdays share admission.